Call control method, communication system, and relevant devices
    1.
    发明授权
    Call control method, communication system, and relevant devices 有权
    呼叫控制方式,通信系统和相关设备

    公开(公告)号:US08335201B2

    公开(公告)日:2012-12-18

    申请号:US12823645

    申请日:2010-06-25

    IPC分类号: H04W4/00 H04L12/28

    摘要: A call control method, a communication system, and relevant devices are provided so that communications can be implemented under different network conditions based on the same number. The method includes: receiving a call request of a calling terminal, where the call request carries a called terminal number; querying a Home Location Register (HLR) of a called terminal according to the called terminal number; obtaining a Supplementary Service Code (SS_Code) from the HLR, where the SS_Code carries a Mobile Station International ISDN Number (MSISDN)-based IP Multimedia Subsystem (IMS) service identifier; and triggering an Application Server (AS) to implement an MSISDN-based IMS service according to the MSISDN-based IMS service identifier. A communication system and relevant devices are also provided.

    摘要翻译: 提供呼叫控制方法,通信系统和相关设备,使得可以在不同的网络条件下基于相同的号码来实现通信。 该方法包括:接收主叫终端的呼叫请求,呼叫请求携带被叫终端号码; 根据被叫终端号查询被叫终端的归属位置寄存器(HLR); 从HLR获得补充业务码(SS_Code),其中SS_Code携带基于移动台国际ISDN号码(MSISDN)的IP多媒体子系统(IMS)服务标识符; 并触发应用服务器(AS)根据基于MSISDN的IMS服务标识符实现基于MSISDN的IMS服务。 还提供通信系统和相关设备。

    Call Control Method, Communication System, and Revelant Devices
    2.
    发明申请
    Call Control Method, Communication System, and Revelant Devices 有权
    呼叫控制方法,通信系统和Revelant设备

    公开(公告)号:US20110110298A1

    公开(公告)日:2011-05-12

    申请号:US12823645

    申请日:2010-06-25

    IPC分类号: H04W4/00

    摘要: A call control method, a communication system, and relevant devices are provided so that communications can be implemented under different network conditions based on the same number. The method includes: receiving a call request of a calling terminal, where the call request carries a called terminal number; querying a Home Location Register (HLR) of a called terminal according to the called terminal number; obtaining a Supplementary Service Code (SS_Code) from the HLR, where the SS_Code carries a Mobile Station International ISDN Number (MSISDN)-based IP Multimedia Subsystem (IMS) service identifier; and triggering an Application Server (AS) to implement an MSISDN-based IMS service according to the MSISDN-based IMS service identifier. A communication system and relevant devices are also provided.

    摘要翻译: 提供呼叫控制方法,通信系统和相关设备,使得可以在不同的网络条件下基于相同的号码来实现通信。 该方法包括:接收主叫终端的呼叫请求,呼叫请求携带被叫终端号码; 根据被叫终端号查询被叫终端的归属位置寄存器(HLR); 从HLR获得补充业务码(SS_Code),其中SS_Code携带基于移动台国际ISDN号码(MSISDN)的IP多媒体子系统(IMS)服务标识符; 并触发应用服务器(AS)根据基于MSISDN的IMS服务标识符实现基于MSISDN的IMS服务。 还提供通信系统和相关设备。

    Method, system and equipment for shifting call based on a mobile terminal with the same number and a soft terminal
    3.
    发明授权
    Method, system and equipment for shifting call based on a mobile terminal with the same number and a soft terminal 有权
    基于具有相同号码的移动终端和软终端转移呼叫的方法,系统和设备

    公开(公告)号:US08270982B2

    公开(公告)日:2012-09-18

    申请号:US12886178

    申请日:2010-09-20

    IPC分类号: H04W36/00

    摘要: A method for switching call between a mobile terminal with the same number and a soft terminal includes: receiving the switching instruction information sent by the soft terminal user during the call between the soft terminal or the mobile terminal with the same number and the opposing user; confirming the type of the switching instruction information, and carrying out the switching performance between the mobile terminal with the same number and the soft terminal according to the type of the switching instruction information. A system and an equipment for switching call between a mobile terminal with the same number and a PC client are disclosed in the present invention.

    摘要翻译: 一种用于在具有相同号码的移动终端和软终端之间切换呼叫的方法包括:在软终端或具有相同号码的移动终端之间的呼叫期间接收由软终端用户发送的切换指令信息,以及相对用户; 确认切换指令信息的类型,并且根据切换指令信息的类型,在相同号码的移动终端和软终端之间执行切换性能。 在本发明中公开了用于在具有相同号码的移动终端和PC客户端之间切换呼叫的系统和设备。

    Lansoprazole formulations and related processes and methods
    5.
    发明申请
    Lansoprazole formulations and related processes and methods 审中-公开
    兰索拉唑制剂及相关方法和方法

    公开(公告)号:US20060140985A1

    公开(公告)日:2006-06-29

    申请号:US10541703

    申请日:2004-01-08

    IPC分类号: A61K31/4439 A61K9/00

    CPC分类号: A61K9/0019 A61K31/4439

    摘要: The invention provides novel liquid lansoprazole formulations comprising lansoprazole and an excipient system, wherein: (a) the concentration of lansoprazole in the formulations ranges from about 0.3 mg/mL to about 50 mg/mL; (b) the excipient system comprises either a single excipient, or a combination of two to four compositionally distinct excipients; and (c) the formulations may be administered parenterally to a mammal to treat or prevent a gastrointestinal disorder.

    摘要翻译: 本发明提供了包含兰索拉唑和赋形剂体系的新型液体兰索拉唑制剂,其中:(a)制剂中兰索拉唑的浓度范围为约0.3mg / mL至约50mg / mL; (b)赋形剂体系包括单一赋形剂或两至四种组合不同赋形剂的组合; 和(c)制剂可以肠胃外给予哺乳动物以治疗或预防胃肠道疾病。

    Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
    7.
    发明授权
    Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses 有权
    2,6-二异丙基苯酚(丙泊酚)的水性药物组合物及其用途

    公开(公告)号:US07550155B2

    公开(公告)日:2009-06-23

    申请号:US10766631

    申请日:2004-01-28

    IPC分类号: A61K9/14

    摘要: The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e.g., by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.

    摘要翻译: 本发明提供含有亲脂性治疗剂的含水药物组合物。 特别地,本发明提供含有化合物2,6-二异丙基苯酚(丙泊酚)的含水药物组合物。 在至少一种嵌段共聚物(例如P188或其他泊洛沙姆)和聚乙二醇(PEG)的存在下,本发明的优选组合物含有异丙酚。 本发明的组合物优选是无菌的或容易灭菌(例如通过高压灭菌),并且适用于对包括人在内的任何动物肠胃外给药。 组合物在宽范围的环境条件下和长时间内也是化学和物理稳定的。

    Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses
    8.
    发明申请
    Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses 有权
    2,6-二异丙基苯酚(异丙酚)的水性药物组合物及其用途

    公开(公告)号:US20090093549A1

    公开(公告)日:2009-04-09

    申请号:US12333887

    申请日:2008-12-12

    IPC分类号: A61K31/05

    摘要: The present invention provides aqueous pharmaceutical compositions containing a lipophilic therapeutic agent. In particular, the invention provides aqueous pharmaceutical compositions containing the compound 2,6-diisopropylphenol (propofol). Preferred compositions of the invention contain propofol in the presence of at least one block copolymer (for example, P188 or another poloxamer) and a polyethylene glycol (PEG). Compositions of the invention are preferably sterile or are readily sterilized (e.g., by autoclaving) and are suitable for parenteral administration to any animal, including humans. The compositions are also chemically and physically stable over a wide range of environmental conditions and for extended periods of time.

    摘要翻译: 本发明提供含有亲脂性治疗剂的含水药物组合物。 特别地,本发明提供含有化合物2,6-二异丙基苯酚(丙泊酚)的含水药物组合物。 在至少一种嵌段共聚物(例如P188或其他泊洛沙姆)和聚乙二醇(PEG)的存在下,本发明的优选组合物含有异丙酚。 本发明的组合物优选是无菌的或容易灭菌(例如通过高压灭菌),并且适用于对包括人在内的任何动物肠胃外给药。 组合物在宽范围的环境条件下和长时间内也是化学和物理稳定的。